Fig. 3. Gamma passing rate with the 2%/2-mm criterion as a function of dose rates for lung, prostate, and head and neck (H&N) disease sites (**P<0.01 and ***P<0.001).

Progress in Medical Physics 2021;32:116-21 https://doi.org/10.14316/pmp.2021.32.4.116

© 2021 Progress in Medical Physics